Table of Content

1 INTRODUCTION
    1.1 OBJECTIVES OF THE STUDY 
    1.2 MARKET DEFINITION 
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY 
    1.5 STAKEHOLDERS 
    1.6 SUMMARY OF CHANGES 
    1.7 RECESSION IMPACT 
2 RESEARCH METHODOLOGY 
    2.1 RESEARCH DATA 
    2.2 RESEARCH APPROACH 
    2.3 RESEARCH METHODOLOGY DESIGN 
    2.4 MARKET SIZE ESTIMATION 
    2.5 MARKET BREAKDOWN AND DATA TRIANGULATION 
    2.6 RESEARCH ASSUMPTIONS  
    2.7 RISK ASSESSMENT 
    2.8 RESEARCH LIMITATIONS 
           2.8.1 METHODOLOGY-RELATED LIMITATIONS 
           2.8.2 SCOPE-RELATED LIMITATIONS 
    2.9 RECESSION IMPACT 
3 EXECUTIVE SUMMARY 
4 PREMIUM INSIGHTS 
5 MARKET OVERVIEW 
    5.1 MARKET DYNAMICS  
           5.1.1 DRIVERS 
           5.1.2 RESTRAINTS 
           5.1.3 OPPORTUNITIES 
           5.1.4 CHALLENGES 
    5.2 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
    5.3 INDUSTRY TRENDS 
    5.4 ECOSYSTEM ANALYSIS 
    5.5 VALUE CHAIN ANALYSIS 
    5.6 TECHNOLOGY ANALYSIS  
           5.6.1 KEY TECHNOLOGIES
           5.6.2 ADJACENT TECHNOLOGIES
    5.7 TARIFF AND REGULATORY LANDSCAPE  
           5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 
           5.7.2 REGULATORY ANALYSIS 
                    5.7.2.1 North America 
                    5.7.2.2 Europe 
                    5.7.2.3 Asia Pacific 
                    5.7.2.4 Latin America
                    5.7.2.5 Middle East & Africa 
    5.8 PRICING ANALYSIS 
           5.8.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY COMPONENT
           5.8.2 AVERAGE SELLING PRICE TREND, BY REGION 
    5.9 PORTER’S FIVE FORCES ANALYSIS 
    5.10 PATENT ANALYSIS 
    5.11 KEY STAKEHOLDERS AND BUYING CRITERIA  
           5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 
           5.11.2 BUYING CRITERIA 
    5.12 END USER ANALYSIS 
           5.9.1 UNMET NEEDS
           5.9.2 END USER EXPECTATIONS 
    5.13 KEY CONFERENCES & EVENTS IN 2023-2024 
    5.14 BUSINESS MODELS 
    5.15 USE CASES/CASE STUDIES 
6 CLINICAL COMMUNICATION & COLLABORATION MARKET, BY PLATFORM TYPE  
    6.1 INTRODUCTION 
    6.2 COLLABORATION PLATFORMS 
    6.3 MESSAGING PLATFORMS 
    6.4 VOICE COMMUNICATION PLATFORMS 
    6.5 OTHERS ( PATIENT ENAGAGEMENT PLATFORMS,EMERGENCY COMMUNICATION SYSTEMS)) 
7 CLINICAL COMMUNICATION & COLLABORATION MARKET, BY COMPONENT  
    7.1 INTRODUCTION 
    7.2 HARDWARE 
           7.2.1 BADGES
           7.2.2 DEDICATED DESKTOP COMPUTERS
           7.2.3 DEDICATED SMARTPHONES & TABLETS
                    7.2.3.1 ANDROID
                    7.2.3.2 IOS
           7.2.4 INTERACTIVE WHITEBOARDS
           7.2.5 NURSE CALL SYSTEMS
           7.2.6 TWO-WAY RADIOS
           7.2.7 VOICE-OVER IP (VOIP) HANDSETS
           7.2.8 WEARABLE COMMUNICATION DEVICES
           7.2.9 WORKSTATION ON WHEELS (WOWS)
    7.3 SOFTWARE 
           7.3.1 CLINICAL ALERTING & NOTIFICATION
           7.3.2 PHYSICIAN & NURSE SCHEDULING SYSTEMS
           7.3.3 TELEHEALTH PLATFORM
           7.3.4 COLLABORATIVE CARE PLATFORMS
    7.4 SERVICES 
           7.4.1 CONSULTING & TRAINING
           7.4.2 IMPLEMENTATION & INTEGRATION
           7.4.3 SUPPORT & MAINTENANCE
8 CLINICAL COMMUNICATION & COLLABORATION MARKET, BY DEPLOYMENT MODEL  
    8.1 INTRODUCTION 
    8.2 ON-PREMISE MODEL 
    8.3 CLOUD-BASED MODEL 
9 CLINICAL COMMUNICATION & COLLABORATION MARKET, BY APPLICATION 
    9.1 INTRODUCTION 
    9.2 LAB & RADIOLOGY COMMUNICATION 
    9.3 NURSE COMMUNICATION 
    9.4 PATIENT COMMUNICATION & EMERGENCY ALERTS 
    9.5 PHYSICIAN COMMUNICATION 
10 CLINICAL COMMUNICATION & COLLABORATION MARKET, BY END USER 
     10.1 INTRODUCTION 
     10.2 HOSPITALS & CLINICS 
     10.3 AMBULATORY SURGICAL CENTERS 
     10.4 LONG-TERM CARE FACILITIES 
     10.5 NURSING CENTERS 
     10.6 OTHERS (MATERNITY CARE CENTERS & FERTILITY CENTERS, TRAUMA & EMERGENCY CARE CENTERS) 
11 CLINICAL COMMUNICATION & COLLABORATION MARKET, BY REGION  
     11.1 INTRODUCTION  
     11.2 NORTH AMERICA  
             11.2.1 US 
             11.2.2 CANADA 
             11.2.3 NORTH AMERICA: IMPACT OF ECONOMIC RECESSION
     11.3 EUROPE  
             11.3.1 GERMANY 
             11.3.2 FRANCE 
             11.3.3 UK 
             11.3.4 ITALY 
             11.3.5 SPAIN 
             11.3.6 REST OF EUROPE 
             11.3.7 EUROPE: IMPACT OF ECONOMIC RECESSION
     11.4 ASIA PACIFIC  
             11.4.1 CHINA 
             11.4.2 JAPAN 
             11.4.3 INDIA 
             11.4.4 REST OF ASIA PACIFIC
             11.4.5 ASIA PACIFIC: IMPACT OF ECONOMIC RECESSION
     11.5 LATIN AMERICA  
             11.5.1 BRAZIL
             11.5.2 MEXICO
             11.5.3 REST OF LATIN AMERICA
             11.5.4 LATIN AMERICA: IMPACT OF ECONOMIC RECESSION
     11.6 MIDDLE EAST AND AFRICA  
             11.6.1 GCC COUNTRIES
             11.6.2 REST OF MIDDLE EAST & AFRICA
             11.6.3  MIDDLE EAST & AFRICA: IMPACT OF ECONOMIC RECESSION
12 COMPETITIVE LANDSCAPE  
     12.1 OVERVIEW  
     12.2 STRATEGIES ADOPTED BY KEY PLAYERS  
     12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS  
     12.4 MARKET SHARE/RANKING ANALYSIS  
     12.5 BRAND/PRODUCT COMPARATIVE ANALYSIS 
     12.6 VALUATION AND FINANCIAL METRICS OF KEY HEALTHCARE DISTRIBUTION VENDORS 
     12.7 COMPANY EVALUATION MATRIX 
             12.7.1 STARS 
             12.7.2 EMERGING LEADERS 
             12.7.3 PERVASIVE PLAYERS 
             12.7.4 PARTICIPANTS 
             12.7.5 COMPANY FOOTPRINT
                        12.7.5.1 OVERALL COMPANY FOOTPRINT
                        12.7.5.2 APLLICATION FOOTPRINT
                        12.7.5.3 END-USER FOOTPRINT
                        12.7.5.4 REGIONAL FOOTPRINT
     12.8 START- UP/SME EVALUATION MATRIX 
             12.8.1 PROGRESSIVE COMPANIES 
             12.8.2 RESPONSIVE COMPANIES 
             12.8.3 DYNAMIC COMPANIES
             12.8.4 STARTING BLOCKS
             12.8.5 COMPETITIVE BENCHMARKING
                        12.8.5.1 DETAILED LIST OF START-UPS/SMES
                        12.8.5.2 COMPETITIVE BEMCHMARKING OF KEY START-UPS/SMES
     12.9 COMPETITIVE SCENARIO AND TRENDS 
             12.9.1 PRODUCT LAUNCHES
             12.9.2 DEALS
             12.9.3 OTHERS
13 COMPANY PROFILES 
     13.1 KEY PLAYERS 
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats)*
             13.1.1 AVAYA LLC
             13.1.2 ORACLE CORPORATION
             13.1.3 CISCO SYSTEMS INC.
             13.1.4 MICROSOFT CORPORATION
             13.1.5 BAXTER INTERNATIONAL (HILLROM)
             13.1.6 SYMPLR
             13.1.7 NEC CORPORATION
             13.1.8 SPOK HOLDINGS INC.
             13.1.9 STRYKER
             13.1.10 PLANTRONICS, INC.
             13.1.11 MOBILE HEARTBEAT.
             13.1.12 ONPAGE.
             13.1.13 UNIPHY HEALTH
             13.1.14 EPIC SYSTEMS CORPORATION.
             13.1.15 ASCOM HOLDING AG
             13.1.16 HIDDEN BRAINS INFOTECH.
             13.1.17 IMPRIVATA, INC.
             13.1.18 EVERBRIDGE.
             13.1.19 JIVE SOFTWARE, LLC
             13.1.20 YRO SYSTEMS PRIVATE LIMITED.
     13.2 OTHER PLAYERS 
             13.2.1 PERFECTSERVE, INC.
             13.2.2 TELMEDIQ
             13.2.3 SLACK TECHNOLOGIES, LLC, A SALESFORCE COMPANY.
             13.2.4 TIGERCONNECT
             13.2.5 ANDOR HEALTH
14 APPENDIX 
     14.1 DISCUSSION GUIDE 
     14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     14.3 AVAILABLE CUSTOMIZATIONS 
     14.4 RELATED REPORTS 
     14.5 AUTHOR DETAILS 
 
*The segmentation of the study can be updated during the course of the study based on primary insights and secondary research
*The list of companies mentioned above is indicative only and might change during the course of the study. A total of 20-25 companies will be provided in the report.
*Details on key financials might not be captured in case of unlisted companies.